عنوان

Conflict of interest and medical innovation :

شابک

0309301688

شابک

9780309301688

شماره

b426092

عنوان اصلي

Conflict of interest and medical innovation :

نام عام مواد

[Book]

ساير اطلاعات عنواني

ensuring integrity while facilitating innovation in medical research : workshop summary /

نام نخستين پديدآور

Sarah H. Beachy, Adam C. Berger, and Steve Olson, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies

نام خاص و کميت اثر

xix, 78 pages :

ساير جزييات

illustrations ;

ابعاد

23 cm

متن يادداشت

Includes bibliographical references (pages 49-51)

متن يادداشت

Introduction and overview -- Conflict of interest policies: an overview -- Perspectives on conflict of interest policies -- Public perceptions of conflict of interest -- Managing conflict and facilitating innovation

بدون عنوان

0

متن يادداشت

"Scientific advances such as the sequencing of the human genome have created great promise for improving human health by providing a greater understanding of disease biology and enabling the development of new drugs, diagnostics, and preventive services. However, the translation of research advances into clinical applications has so far been slower than anticipated. This is due in part to the complexity of the underlying biology as well as the cost and time it takes to develop a product. Pharmaceutical companies are adapting their business models to this new reality for product development by placing increasing emphasis on leveraging alliances, joint development efforts, early-phase research partnerships, and public-private partnerships. These collaborative efforts make it possible to identify new drug targets, enhance the understanding of the underlying basis of disease, discover novel indications for the use of already approved products, and develop biomarkers for disease outcomes or directed drug use. While the potential benefits of collaboration are significant, the fact that the relationships among development partners are often financial means that it is vital to ensure trust by identifying, disclosing, and managing any potential sources of conflict that could create bias in the research being performed together."Conflict of Interest and Medical Innovation" is the summary of a workshop convened by the Institute of Medicine Roundtable on Translating Genomic-Based Research for Health in June 2013 to explore the appropriate balance between identifying and managing conflicts of interest and advancing medical innovation. A wide range of stakeholders, including government officials, pharmaceutical company representatives, academic administrators and researchers, health care providers, medical ethicists, patient advocates, and consumers, were invited to present their perspectives and participate in discussions during the workshop. This report focuses on current conflict of interest policies and their effect on medical innovation in an effort to identify best practices and potential solutions for facilitating innovation while still ensuring scientific integrity and public trust"--Publisher's description

عنوان اصلي به زبان ديگر

Ensuring integrity while facilitating innovation in medical research

موضوع مستند نشده

Conflict of interests, Congresses

موضوع مستند نشده

Medicine-- Research-- Moral and ethical aspects, Congresses

مستند نام اشخاص تاييد نشده

Beachy, Sarah H.

مستند نام اشخاص تاييد نشده

Berger, Adam C.

مستند نام اشخاص تاييد نشده

Olson, Steve,1956-

مستند نام تنالگان تاييد نشده

Conflict of Interest and Medical Innovation : Ensuring Integrity While Facilitating Innovation in Medical Research (Workshop)(2013 :, Washington, D.C.)

مستند نام تنالگان تاييد نشده

Institute of Medicine (U.S.)., Roundtable on Translating Genomic-Based Research for Health,issuing body

تاريخ عمليات

20141129053307.0

قواعد فهرست نويسي ( بخش توصيفي )

rda

نام الکترونيکي

نوع ماده

[Book]

تكميل شده

Y